» Articles » PMID: 24797971

Quality of Life in Polish Patients with Multiple Sclerosis

Overview
Journal Adv Med Sci
Publisher Elsevier
Specialty General Medicine
Date 2014 May 7
PMID 24797971
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study is a pilot evaluation of the quality of life (QoL) in Polish patients with multiple sclerosis (MS).

Material/methods: Data from 21 centers in Poland were collected from May 2008 to January 2009. QoL was assessed using the questionnaire Euro Quality of Life (EQ-5D), with Polish population norms. Demographic profile of patients, duration/form/relapsing activity of the disease, disability and comorbidity were also analyzed.

Results: Data from 3521 patients (F/M ratio 2.4:1) were collected. The average EQ-5D index was 0.8 ± 0.27 and the mean score in a visual analog scale (EQ-VAS) was 65.6 ± 21.5. There was a highly significant positive correlation between both indices (r=0.7334, p<0.0001). The mean patient age was 40.7 years (11.2-92.3 years) and disease duration was 10.3 ± 8.8 years (0.04-53 years). 74.2% of subjects had relapsing-remitting form of MS, while 17.2% were classified as secondary progressive and 8.6% as primary progressive. In the group of relapsing-remitting MS subjects there were 2.5% patients with "benign MS". The average degree of disability on EDSS scale was 3.6 ± 2.2, while disability ≥6 was observed in 20.3% of patients. Most patients did not have other diseases besides MS.

Conclusions: This is the first large study of QoL in patients with MS in Poland (approximately 18% of all patients). Our results confirm a reduction in QoL compared with the general population. Further studies are indicated to identify the modifiable risk factors (e.g. type of treatment) that may affect QoL.

Citing Articles

Post-acute (long) COVID-19 quality of life: validation of the German version of (PAC19QoL) instrument.

Umakanthan S, Monice M, Mehboob S, Jones C, Lawrence S Front Public Health. 2023; 11:1163360.

PMID: 37457286 PMC: 10349205. DOI: 10.3389/fpubh.2023.1163360.


Quality of life assessment in migraine and relapsing remitting multiple sclerosis: self-perceived health is similar.

Glavor K, Titlic M, Vuletic G, Mrden A, Simunic M Neurol Sci. 2019; 40(12):2549-2554.

PMID: 31317351 DOI: 10.1007/s10072-019-04005-z.


EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review.

Rupel V, Divjak M, Zrubka Z, Rencz F, Gulacsi L, Golicki D Eur J Health Econ. 2019; 20(Suppl 1):109-117.

PMID: 31098882 DOI: 10.1007/s10198-019-01068-9.


Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D.

Niedziela N, Pierzchala K, Zalejska-Fiolka J, Niedziela J, Romuk E, Torbus-Paluszczak M Biomed Res Int. 2018; 2018:9329123.

PMID: 30211230 PMC: 6126066. DOI: 10.1155/2018/9329123.


Quality of life among multiple sclerosis patients in Saudi Arabia.

Algahtani H, Shirah B, AlZahrani F, Abobaker H, Alghanaim N, Manlangit Jr J Neurosciences (Riyadh). 2017; 22(4):261-266.

PMID: 29057850 PMC: 5946374. DOI: 10.17712/nsj.2017.4.20170273.